Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

132
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
132
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

299
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
299
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pilot Test of a Diet Cost Calculation Process for Use in Economic Evaluations of Dietary Interventions.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2026
Same author

Xpert Ultra on nasopharyngeal swabs detects one-third of pulmonary tuberculosis: a nested case-control study in South African primary care.

Research square·2026
Same author

Microbial product translocation and mortality in adults hospitalised with HIV-associated tuberculosis: a prospective observational cohort study.

Research square·2026
Same author

Differential target multiplexed SCS (DTM SCS): a rational hypothesis.

Pain medicine (Malden, Mass.)·2026
Same author

History of SCS and patient-focused innovations: a manufacturer's perspective on the role of technology.

Pain medicine (Malden, Mass.)·2026
Same author

Deep learning approach for probabilistic pulmonary function estimation from chest X-ray and peak expiratory flow rate.

Communications medicine·2026

Related Experiment Video

Updated: May 30, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.7K

Tuberculosis: An Update for the Clinician.

Saskia Janssen1,2, Melissa Murphy1, Caryn Upton1

  • 1TASK, Cape Town, South Africa.

Respirology (Carlton, Vic.)
|January 31, 2025
PubMed
Summary

Tuberculosis (TB) is a major global health issue, with subclinical cases significantly contributing to its spread. New vaccines and treatments offer hope, but challenges like drug resistance and post-TB lung disease require continued research and investment.

Keywords:
diagnosticspost‐tuberculosis lung diseasepreventiontreatmenttuberculosis

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.0K

Related Experiment Videos

Last Updated: May 30, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.7K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.0K

Area of Science:

  • Infectious Diseases
  • Public Health
  • Vaccinology
  • Pharmacology

Background:

  • Tuberculosis (TB) remains a leading cause of mortality globally, with current strategies to meet World Health Organization (WHO) End TB targets falling short.
  • The understanding of TB has evolved from distinct latent and active forms to a complex disease spectrum, where subclinical infections play a critical role in transmission.

Purpose of the Study:

  • To review the current landscape of TB control, highlighting recent advancements and persistent challenges in diagnostics, prevention, and treatment.
  • To emphasize the need for continued research and investment in TB vaccines, therapeutics, and management of sequelae.

Main Methods:

  • Review of recent clinical trial data for TB vaccines (e.g., M72/AS01E) and novel therapeutic regimens.
  • Analysis of epidemiological data on TB transmission, including the role of subclinical disease and infectiousness.
  • Assessment of challenges in TB preventive therapy (TPT) implementation and the growing concern of drug resistance.

Main Results:

  • Subclinical TB contributes significantly to transmission, with even paucibacillary cases being highly infectious.
  • The M72/AS01E vaccine shows promising preliminary results, potentially impacting the TB epidemic if confirmed in larger trials.
  • New all-oral, shorter treatment regimens are a breakthrough but are threatened by rising resistance to drugs like bedaquiline.
  • Post-TB lung disease (PTLD) is an under-recognized but significant issue affecting survivors.

Conclusions:

  • Combating TB requires a multi-faceted approach, including the development of effective vaccines and novel therapeutics to overcome drug resistance.
  • Addressing challenges in TPT implementation, managing complex TB cases (CNS TB, HIV-associated TB), and mitigating PTLD are crucial.
  • Sustained investment in TB research and control strategies is essential to curb this ongoing global health threat.